Expertise in
6
conditions

Dr. Richard Bergenstal

Endocrinology
Park Nicollet Clinic-St Louis Park
3800 Park Nicollet Blvd, 
Minneapolis, MN 
Expertise in
6
conditions
Park Nicollet Clinic-St Louis Park
3800 Park Nicollet Blvd, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Bergenstal is an Endocrinologist in Minneapolis, Minnesota. Dr. Bergenstal is highly rated in 6 conditions, according to our data. His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young.

His clinical research consists of co-authoring 281 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in MN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 5 Less Insurance Carriers -

Locations

Park Nicollet Clinic-St Louis Park
3800 Park Nicollet Blvd, Minneapolis, MN 55416
Call: 952-993-3393

Additional Areas of Focus

Dr. Bergenstal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 3
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 03, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Degludec
Study Phase: Phase 2
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Enrollment Status: Completed
Publish Date: April 14, 2022
Intervention Type: Drug
Study Drugs: Glimepiride, Sitagliptin, Liraglutide, Insulin (glargine)
Study Phase: Phase 3
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

281 Total Publications

Continuous Glucose Monitoring.
Continuous Glucose Monitoring.
Journal: JAMA
Published: November 24, 2025
View All 281 Publications
Similar Doctors
Expertise in
4
conditions
Dr. Bernhard J. Hering
Endocrinology
Expertise in
4
conditions
Dr. Bernhard J. Hering
Endocrinology
516 Delaware Street Se, Pwb First Floor, Clinic 1e, Univ. Of Minn. Physicians, 
Minneapolis, MN 
 (6.2 miles away)
612-626-6666
Languages Spoken:
English
See accepted insurances

Bernhard Hering is an Endocrinologist in Minneapolis, Minnesota. Dr. Hering is highly rated in 4 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Obesity, Islet Cell Transplantation, and Pancreatectomy.

Expertise in
4
conditions
Dr. Elizabeth Seaquist
Endocrinology
Expertise in
4
conditions
Dr. Elizabeth Seaquist
Endocrinology

Office

909 Fulton St SE Fl 3, 
Minneapolis, MN 
 (6.1 miles away)
612-625-8690
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Elizabeth Seaquist is an Endocrinologist in Minneapolis, Minnesota. Dr. Seaquist has been practicing medicine for over 44 years is highly rated in 4 conditions, according to our data. Her top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Expertise in
15
conditions
Dr. Gregory Damberg
Endocrinology
Expertise in
15
conditions
Dr. Gregory Damberg
Endocrinology

Park Nicollet Clinic-St Louis Park

3800 Park Nicollet Blvd, 
Minneapolis, MN 
 (0.1 miles away)
952-993-3622
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gregory Damberg is an Endocrinologist in Minneapolis, Minnesota. Dr. Damberg is highly rated in 15 conditions, according to our data. His top areas of expertise are Infantile Low Calcium Level, Thyroid Cancer, Anaplastic Thyroid Cancer, and Follicular Thyroid Cancer.

VIEW MORE Endocrinologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bergenstal's expertise for a condition
ConditionClose
  • Elite
  • Low Blood Sugar
    Dr. Bergenstal is
    Elite
    . Learn about Low Blood Sugar.
    See more Low Blood Sugar experts
  • Maturity Onset Diabetes of the Young
    Dr. Bergenstal is
    Elite
    . Learn about Maturity Onset Diabetes of the Young.
    See more Maturity Onset Diabetes of the Young experts
  • Type 1 Diabetes (T1D)
    Dr. Bergenstal is
    Elite
    . Learn about Type 1 Diabetes (T1D).
    See more Type 1 Diabetes (T1D) experts
  • Type 2 Diabetes (T2D)
    Dr. Bergenstal is
    Elite
    . Learn about Type 2 Diabetes (T2D).
    See more Type 2 Diabetes (T2D) experts
  • Distinguished
  • Diabetic Ketoacidosis
    Dr. Bergenstal is
    Distinguished
    . Learn about Diabetic Ketoacidosis.
    See more Diabetic Ketoacidosis experts
  • Gestational Diabetes
    Dr. Bergenstal is
    Distinguished
    . Learn about Gestational Diabetes.
    See more Gestational Diabetes experts
    • Experienced
    • Diabetic Hyperglycemic Hyperosmolar Syndrome
      Dr. Bergenstal is
      Experienced
      . Learn about Diabetic Hyperglycemic Hyperosmolar Syndrome.
      See more Diabetic Hyperglycemic Hyperosmolar Syndrome experts
    • Diabetic Nephropathy
      Dr. Bergenstal is
      Experienced
      . Learn about Diabetic Nephropathy.
      See more Diabetic Nephropathy experts
    • Obesity
      Dr. Bergenstal is
      Experienced
      . Learn about Obesity.
      See more Obesity experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Endocrinologists Minneapolis, MN
    3. Dr. Richard Bergenstal
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.